The latest closing stock price for Immunovant as of May 16, 2025 is 14.46.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2019 would have $453 today, roughly 0 times their original investment - a 6.43% compound annual growth rate over 6 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 34.47, which is 138.4% above the current share price.
The Immunovant 52-week low stock price is 12.72, which is 12% below the current share price.
The average Immunovant stock price for the last 52 weeks is 24.90.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2019 would have $453 today, roughly 0 times their original investment - a 6.43% compound annual growth rate over 6 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 34.47, which is 138.4% above the current share price.
The Immunovant 52-week low stock price is 12.72, which is 12% below the current share price.
The average Immunovant stock price for the last 52 weeks is 24.90.